- A lot of people hope that the vaccines are ready to fight the Covid 19 pandemic.
- But the new strain of virus in the UK raises questions about the effectiveness of these vaccine.
- A positive news is that AstraZeneca chief believes Covid vaccine will work on variant strain.
- Also, the chief executive of BioNTech said the company is confident its COVID-19 vaccine works against the U.K. variant, but said further studies are needed to be completely sure.
According to a recent news published in the Guardian and the CBC news, despite the new strain of virus in the UK, the medical firms believe that the vaccines would work on the UK variant. But, still it needs a a lot of further studies to be completely sure.
Winning formula
AstraZeneca chief executive, Pascal Soriot says firm has ‘winning formula’ to improve Oxford jab’s efficacy, as countries across Europe roll out vaccination programs.
Soirot said: “So far, we think the vaccine should remain effective. But we can’t be sure, so we’re going to test that.”
“We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else.”
“I can’t tell you more because we will publish at some point.”
BioNTech confident its vaccine works
The chief executive of BioNTech said the company is confident its COVID-19 vaccine works against the U.K. variant, but said further studies are needed to be completely sure.
Children affected
This new strain of virus in the UK is said to create an impact on children. It is 70 % faster in spreading, there is an emergency that people should stay at home. As a result, there has been tough measures in and around the European countries.
France and third nationwide lockdown
France has not ruled out imposing a third nationwide lockdown if coronavirus cases continue to rise, its health minister said Sunday, as the country braces for a possible post-Christmas spike.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: CBC News and The Guardian
